Cardinal Health, Inc.
CAH · NYSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.30 | 0.16 | -0.54 | 0.06 |
| FCF Yield | 4.57% | 13.57% | 9.57% | 18.75% |
| EV / EBITDA | 14.80 | 12.45 | 17.92 | 284.93 |
| Quality | ||||
| ROIC | 11.37% | 8.80% | 3.58% | -4.33% |
| Gross Margin | 3.67% | 3.27% | 3.36% | 3.58% |
| Cash Conversion Ratio | 1.53 | 4.41 | 8.59 | -3.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.78% | 7.75% | 8.06% | 5.84% |
| Free Cash Flow Growth | -43.09% | 37.58% | -13.60% | 34.80% |
| Safety | ||||
| Net Debt / EBITDA | 1.76 | 0.24 | 0.76 | 19.78 |
| Interest Coverage | 10.58 | 24.37 | 8.95 | -4.13 |
| Efficiency | ||||
| Inventory Turnover | 12.74 | 14.67 | 12.29 | 11.18 |
| Cash Conversion Cycle | -8.73 | -8.51 | -5.67 | -2.73 |